In the present study, we investigated whether haplotypes representing common variations in the CRP gene are associated with levels of CRP in patients with acute ischemic stroke.
Methods

Study Population
Patients were derived from the Erasmus Stroke Study, a project aimed at collecting clinical information, blood samples and DNA of all patients with neurovascular diseases admitted to Erasmus University Medical Center.
For the present study, we evaluated all patients with ischemic stroke admitted between December 2005 and December 2008 in whom venous blood was collected within 24 h of symptom onset.
Written informed consent was obtained from all patients, signed by the participants or a first-degree relative, as approved by the Institutional Ethics Committee.
Baseline Characteristics
Baseline clinical information was extracted from the trial records. This included a quantification of stroke severity according to the National Institutes of Health Stroke Scale (NIHSS) [12] , ischemic stroke subtype according to the TOAST classification [13] , and cardiovascular risk factors.
Measurement of CRP
CRP levels were determined by means of the Roche Modular Assay. The range of measurement is 1-285 mg/l with a variation coefficient of 4.6%.
CRP Polymorphism Genotyping
In the Seattle SNPs program for Genomic applications, 31 SNPs were identified in the CRP gene on chromosome 1q21 (http://www.pga.gs.washington.edu/data/crp, 'visual haplotype' option).
In 23 unrelated individuals of European descent, these SNPs formed 4 well-defined haplotypes with frequencies of more than 5%. By selecting 3 tagging SNPs, the total common variation in the CRP gene is described. We selected the following tagging SNPs: 1184 C 1 T (rs1130864), 2042 C 1 T (rs1205) and 2911 C 1 G (rs3093068).
DNA was extracted according to standard procedures and stored at -20 ° C. Genotypes were determined in genomic DNA of 2 ng with the Taqman allelic discrimination assay (Applied Biosystems, Foster City, Calif., USA) and end-point readings of fluorescence were performed on Taqman Prism 7900HT (Applied Biosystems).
Statistical Analysis
SNPs were tested for Hardy-Weinberg equilibrium with a
Results
Between December 2005 and December 2008, 561 patients with ischemic stroke were included in the Erasmus Stroke Study. Of these patients, 376 were excluded for the present study because of CRP measurement was not accomplished within 24 h of stroke onset (n = 140), DNA was not available (226) or genotyping failed for 2 or 3 out of 3 SNPs (n = 10).
In the total study population, the mean age was 64 (SD 15), 53% were male and the median NIHSS score was 4 (range 0-22) ( table 1 ). Mean CRP level was 10 mg/l (SD 27). Median time from onset of symptoms to CRP measurement was approximately 7 h. 
Medical history
Previous stroke, n (%) Previous myocardial infarction, n (%) Peripheral vascular disease, n (%) 50 (27) 31 (17) 13 (7) Stroke subtype* Large vessel disease, ≥50% stenosis, n (%) Cardiac source of embolism, n (%) Small vessel occlusion, n (%) Other determined etiology, n (%) Undetermined/negative evaluation, n (%)
28 (15) 30 (16) 27 (15) 21 (11) All SNPs were in Hardy-Weinberg equilibrium. The 1,184T-allele was present in 25.9%, the 2,042T-allele was present in 34.5% and the 2911G-allele in 8.6% of 370 chromosomes.
Four common haplotypes were identified ( table 2 ) . The remaining haplotypes (CTG, TCG, TTC) were present in less than 5%.
Haplotype 4 (CCG) was associated with a significant stronger increase in CRP level (20.6 mg/l; 95% CI, 9.8-30.4) relative to the reference haplotype 1 (CTC) ( table 2 and fig. 1 ). Adjustment for age, sex and NIHSS score did not attenuate this association ( fig. 1 ).
Discussion
In this study, we found that SNPs in the CRP gene were associated with levels of CRP within 24 h of ischemic stroke onset. Haplotype 4 (CCG) was associated with significant higher levels of CRP than haplotype 1 (CTC).
Our results provide further proof that, apart from environmental factors, genetic variations may influence levels of CRP. Several studies found an association between CRP haplotypes and levels of CRP in diseases in which inflammation is involved [9, 14, 15] . The direction of the haplotype-CRP level associations are also supported by previous studies that have used the same polymorphisms to reconstruct the haplotypes [9, 14, 15] . Two previous studies that investigated the association between SNPs in the CRP gene and levels of CRP in patients with acute ischemic stroke cannot be compared directly with ours, because only single SNPs were studied [3, 11] .
The present study has some limitations. First, the study compromised a small number of patients. As a result, the precision of our estimates is limited. Furthermore, because of this small number of patients we could not adjust the association between CRP haplotypes and levels of CRP for vascular risk factors, like diabetes mellitus and smoking, which might have influenced the levels of CRP. Second, our results did not include information about ethnicity. Allele frequencies have been reported to differ between ethnic groups. However, the haplotype structures are similar and therefore the direction and size of changes in CRP levels associated with most SNPs might be similar regardless of ethnic group [15] .
A third issue that warrants consideration in this study is that DNA was lacking for 226 patients who were admitted within 24 h of symptom onset. On the other hand, comparison of the excluded patients with the study population showed no significant differences with regard to baseline characteristics or case fatality. Hence, it is not likely that it has substantially influenced the results.
Finally, our study focused on CRP levels within 24 h of stroke onset. As CRP may peak several days after ischemic stroke, CRP measured at later time points than in our study may better reflect the magnitude of the inflammatory reaction. Furthermore, we did not have levels of CRP prior to ischemic stroke or several months after the stroke. It would be interesting to compare the association between CRP haplotypes and these levels with that of stroke-free participants. On the other hand, a previous study did not find an association between CRP genotypes and baseline levels of CRP nor between CRP genotypes and levels of CRP in stroke-free participants [10] .
Increases in CRP levels following ischemic stroke may reflect a systemic inflammatory response, the extent of tissue injury, or concurrent infections. Interestingly, in animal models of focal cerebral ischemia, CRP increased * p values were obtained using haplo score, after 2,377 simulations. The frequencies refer to the reference (Seattle) population. secondary brain damage through activation of the complement system [7, 16] . These findings suggest that understanding genotype-phenotype associations of CRP polymorphisms may provide a genetic basis for the future development of tailored therapeutic strategies in ischemic stroke.
In conclusion, variation in the CRP gene is associated with levels of CRP in acute ischemic stroke. Further studies are needed to investigate the relation between variation in the CRP gene, levels of CRP and clinical outcome after acute ischemic stroke.
